Georgette Beatriz de Paula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Georgette Beatriz de Paula has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Andréa Trevas Maciel-Guerra
Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil
3 shared publications - Gil Guerra-Júnior
Growth and Development Laboratory (LabCreD), Center for Investigation in Pediatrics, School of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil
3 shared publications - Guilherme Guaragna-Filho
Department of Pediatrics, UFRGS, Post-graduate Program in Child and Adolescent Health, Faculty of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
3 shared publications - Maricilda Palandi de Mello
Universidade Estadual de Campinas (UNICAMP), Brazil
3 shared publications - Antonia Paula Marques-De-Faria
Departamento de Genética Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil
2 shared publications - Beatriz Amstalden Barros
Interdisciplinary Group for Studies of Sex Determination and Differentiation (GIEDDS), Faculty of Medical Sciences and Clinical Hospital, State University of Campinas (UNICAMP), 13083-887 Campinas, Sao Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 7 February 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 163-170
Leydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion: a case-control study
Because normal male sexual differentiation is more complex than normal female sexual differentiation, there are more cases of disorders of sex development (DSDs) with 46,XY karyotype that have unclear etiology. However, Leydig and Sertoli cell markers are rarely used in distinguishing such individuals. To evaluate the function of Leydig and Sertoli cells in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion. Case-control study with 77 patients, including eight with partial androgen insensitivity syndrome, eight with 5α-reductase deficiency type 2 (5ARD2) and 19 with idiopathic 46,XY DSD, and 42 healthy controls, from the Interdisciplinary Study Group for Sex Determination and Differentiation (GIEDDS), at the State University of Campinas (UNICAMP), Campinas, Brazil. Baseline levels of gonadotropins, anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), testosterone and dihydrotestosterone in cases, and AMH, inhibin B, and INSL3 levels in controls, were assessed. There was no significant difference in age between cases and controls (P = 0.595). AMH and inhibin B levels were significantly lower in cases than in controls (P = 0.031 and P < 0.001, respectively). INSL3 levels were significantly higher in cases than in controls (P = 0.003). Inhibin B levels were lower in 5ARD2 patients (P = 0.045) and idiopathic patients (P = 0.001), in separate comparisons with the controls. According to our findings, we can speculate that inhibin B levels may be used to differentiate among DSD cases.
- 7 February 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 163-170
Open AccessLeydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion: a case-control study
Because normal male sexual differentiation is more complex than normal female sexual differentiation, there are more cases of disorders of sex development (DSDs) with 46,XY karyotype that have unclear etiology. However, Leydig and Sertoli cell markers are rarely used in distinguishing such individuals. To evaluate the function of Leydig and Sertoli cells in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion. Case-control study with 77 patients, including eight with partial androgen insensitivity syndrome, eight with 5α-reductase deficiency type 2 (5ARD2) and 19 with idiopathic 46,XY DSD, and 42 healthy controls, from the Interdisciplinary Study Group for Sex Determination and Differentiation (GIEDDS), at the State University of Campinas (UNICAMP), Campinas, Brazil. Baseline levels of gonadotropins, anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), testosterone and dihydrotestosterone in cases, and AMH, inhibin B, and INSL3 levels in controls, were assessed. There was no significant difference in age between cases and controls (P = 0.595). AMH and inhibin B levels were significantly lower in cases than in controls (P = 0.031 and P < 0.001, respectively). INSL3 levels were significantly higher in cases than in controls (P = 0.003). Inhibin B levels were lower in 5ARD2 patients (P = 0.045) and idiopathic patients (P = 0.001), in separate comparisons with the controls. According to our findings, we can speculate that inhibin B levels may be used to differentiate among DSD cases.
- Open Access
- 1 September 2020
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 96 (5) , 607-613
Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- 1 September 2020
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 96 (5) , 607-613
Open AccessWhy pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- Open Access
- 27 June 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 96 (5) , 607-613
Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- 27 June 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 96 (5) , 607-613
Open AccessWhy pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service